Point of care lung ultrasound in preschool children with cystic fibrosis: a case-controlled, prospective, pilot study.
primary studies published, non RCT
Details- 2024
- Crispino AA
Successful Therapy over 12 Months of People with Cystic Fibrosis with Rare Non-phe508del Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations with Elexacaftor/Tezacaftor/Ivacaftor (ETI).
primary studies published, non RCT
Details- 2024
- Sütering T
Long-term therapy with CFTR modulators consistently improves glucose metabolism in adolescents and adults with cystic fibrosis.
primary studies published, non RCT
Details- 2024
- Cohen A
The long-term effect of elexacaftor/tezacaftor/ivacaftor on cardiorespiratory fitness in adolescent patients with cystic fibrosis: a pilot observational study.
primary studies published, non RCT
Details- 2024
- Stastna N
Long-term outcomes of early exposure to repeated general anaesthesia in children with cystic fibrosis (CF-GAIN): a multicentre, open-label, randomised controlled phase 4 trial.
primary studies published, non RCT
Details- 2024
- Wainwright CE
Airway clearance therapy in the school environment: Retrospective analysis of a cohort of pediatric patients with cystic fibrosis.
primary studies published, non RCT
Details- 2023
- Byrwa DJ
Echocardiographic assessment of cardiovascular involvements in children with cystic fibrosis.
primary studies published, non RCT
Details- 2024
- Ghaffaripour H
Impact of chronic medication de-escalation in patients with cystic fibrosis taking elexacaftor, tezacaftor, ivacaftor: A retrospective review.
primary studies published, non RCT
Details- 2024
- Guenther EL
Peri-operative and long-term outcomes of kidney transplantation in patients with cystic fibrosis.
primary studies published, non RCT
Details- 2024
- O'Kelly JA
Improvement in Lung Clearance Index and Chest CT Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Study.
primary studies published, non RCT
Details- 2023
- McNally P